Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aspire Biopharma Holdings, Inc. - Common Stock (NQ:ASBP)

0.3433 +0.0079 (+2.36%)
Streaming Delayed Price Updated: 12:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 58,462
Open 0.3370
Bid (Size) 0.3402 (4)
Ask (Size) 0.3480 (3)
Prev. Close 0.3354
Today's Range 0.3300 - 0.3433
52wk Range 0.3200 - 9.860
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21
Via ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga

Performance

YTD
-94.4%
-94.4%
1 Month
-21.8%
-21.8%
3 Month
-94.4%
-94.4%
6 Month
-94.4%
-94.4%
1 Year
-94.4%
-94.4%

More News

Read More
Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Via ACCESS Newswire
Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
Via ACCESS Newswire
Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement
Via ACCESS Newswire
Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Via ACCESS Newswire
Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin
Via ACCESS Newswire
Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
Via ACCESS Newswire
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation
Via Newsfile
Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement
Via ACCESS Newswire
Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
Via ACCESS Newswire
Dow Tumbles Over 700 Points; US Services PMI Falls In February
Via Benzinga
Topics Stocks
Exposures US Equities
Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement
Via ACCESS Newswire

Frequently Asked Questions

Is Aspire Biopharma Holdings, Inc. - Common Stock publicly traded?
Yes, Aspire Biopharma Holdings, Inc. - Common Stock is publicly traded.
What exchange does Aspire Biopharma Holdings, Inc. - Common Stock trade on?
Aspire Biopharma Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aspire Biopharma Holdings, Inc. - Common Stock?
The ticker symbol for Aspire Biopharma Holdings, Inc. - Common Stock is ASBP on the Nasdaq Stock Market
What is the current price of Aspire Biopharma Holdings, Inc. - Common Stock?
The current price of Aspire Biopharma Holdings, Inc. - Common Stock is 0.3433
When was Aspire Biopharma Holdings, Inc. - Common Stock last traded?
The last trade of Aspire Biopharma Holdings, Inc. - Common Stock was at 05/09/25 12:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.